208 related articles for article (PubMed ID: 10906330)
1. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library.
Deng SJ; Bickett DM; Mitchell JL; Lambert MH; Blackburn RK; Carter HL; Neugebauer J; Pahel G; Weiner MP; Moss ML
J Biol Chem; 2000 Oct; 275(40):31422-7. PubMed ID: 10906330
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of human collagenase-3.
Knäuper V; López-Otin C; Smith B; Knight G; Murphy G
J Biol Chem; 1996 Jan; 271(3):1544-50. PubMed ID: 8576151
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
Xia T; Akers K; Eisen AZ; Seltzer JL
Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038
[TBL] [Abstract][Full Text] [Related]
5. Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.
Park HI; Turk BE; Gerkema FE; Cantley LC; Sang QX
J Biol Chem; 2002 Sep; 277(38):35168-75. PubMed ID: 12119297
[TBL] [Abstract][Full Text] [Related]
6. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.
Knäuper V; Cowell S; Smith B; López-Otin C; O'Shea M; Morris H; Zardi L; Murphy G
J Biol Chem; 1997 Mar; 272(12):7608-16. PubMed ID: 9065415
[TBL] [Abstract][Full Text] [Related]
7. Sequence specificities of human fibroblast and neutrophil collagenases.
Netzel-Arnett S; Fields GB; Birkedal-Hansen H; Van Wart HE
J Biol Chem; 1991 Apr; 266(11):6747-55. PubMed ID: 1849891
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
9. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses.
Eckhard U; Huesgen PF; Schilling O; Bellac CL; Butler GS; Cox JH; Dufour A; Goebeler V; Kappelhoff R; Keller UAD; Klein T; Lange PF; Marino G; Morrison CJ; Prudova A; Rodriguez D; Starr AE; Wang Y; Overall CM
Matrix Biol; 2016 Jan; 49():37-60. PubMed ID: 26407638
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of type I collagen containing mutated alpha 1(1) chains to cleavage by human neutrophil collagenase.
Hasty KA; Wu H; Byrne M; Goldring MB; Seyer JM; Jaenisch R; Krane SM; Mainardi CL
Matrix; 1993 May; 13(3):181-6. PubMed ID: 8326908
[TBL] [Abstract][Full Text] [Related]
11. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation.
Balbín M; Fueyo A; Knäuper V; López JM; Alvarez J; Sánchez LM; Quesada V; Bordallo J; Murphy G; López-Otín C
J Biol Chem; 2001 Mar; 276(13):10253-62. PubMed ID: 11113146
[TBL] [Abstract][Full Text] [Related]
12. Defining requirements for collagenase cleavage in collagen type III using a bacterial collagen system.
Yu Z; Visse R; Inouye M; Nagase H; Brodsky B
J Biol Chem; 2012 Jun; 287(27):22988-97. PubMed ID: 22573319
[TBL] [Abstract][Full Text] [Related]
13. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W
Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183
[TBL] [Abstract][Full Text] [Related]
14. Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins.
Sanchez-Lopez R; Alexander CM; Behrendtsen O; Breathnach R; Werb Z
J Biol Chem; 1993 Apr; 268(10):7238-47. PubMed ID: 8463259
[TBL] [Abstract][Full Text] [Related]
15. Identification of substrate sequences for membrane type-1 matrix metalloproteinase using bacteriophage peptide display library.
Ohkubo S; Miyadera K; Sugimoto Y; Matsuo K; Wierzba K; Yamada Y
Biochem Biophys Res Commun; 1999 Dec; 266(2):308-13. PubMed ID: 10600499
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen.
Steffensen B; Wallon UM; Overall CM
J Biol Chem; 1995 May; 270(19):11555-66. PubMed ID: 7744795
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.
Fosang AJ; Last K; Knäuper V; Neame PJ; Murphy G; Hardingham TE; Tschesche H; Hamilton JA
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):273-6. PubMed ID: 8216228
[TBL] [Abstract][Full Text] [Related]
18. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Nagase H; Fields CG; Fields GB
J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
[TBL] [Abstract][Full Text] [Related]
19. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
20. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.
Bode W; Reinemer P; Huber R; Kleine T; Schnierer S; Tschesche H
EMBO J; 1994 Mar; 13(6):1263-9. PubMed ID: 8137810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
